Steven B. Zeliadt, PhD

Articles by Steven B. Zeliadt, PhD

Decision Aids for Benign Prostatic Hyperplasia and Prostate Cancer

ByDavid Arterburn, MD, MPH,Robert Wellman, MS,Emily O. Westbrook, MHA,Tyler R. Ross, MA,David McCulloch, MD,Matt Handley, MD,Marc Lowe, MD,Chris Cable, MD,Steven B. Zeliadt, PhD,Richard M. Hoffman, MD, MPH

March 20th 2015

Implementing patient decision aids was associated with lower rates of elective surgery for benign prostatic hyperplasia and of active treatment for localized prostate cancer.

Latest Updated Articles

Decision Aids for Benign Prostatic Hyperplasia and Prostate Cancer
Published: March 20th 2015 | Updated:

Steven B. Zeliadt, PhD

Articles by Steven B. Zeliadt, PhD

Decision Aids for Benign Prostatic Hyperplasia and Prostate Cancer

Latest Updated Articles

Trending on AJMC

Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color

Withdrawal of Aid Could Cause Millions of Lives Lost to HIV

How Socioeconomic and Clinical Factors Influence Obesity Treatment